Portrait of Prof Steve Lord



Download the QuickScreen© order form

What is QuickScreen©?

Since there are many risk factors for falls which vary from person to person, individualised risk factor assessment should be the first step in developing effective intervention strategies for the prevention of falls in older people.

The NeuRA QuickScreen © Clinical Falls Risk Assessment (or QuickScreen © for short) was developed by researchers at Neuroscience Research Australia (NeuRA) and is a multifactorial assessment tool which was designed specifically for use in clinical settings. It has been rigorously tested in a large sample of community-dwelling older people in which it was found that performance in the QuickScreen © was able to accurately predict faller status. In a sub-group of these people, the QuickScreen © measures exhibited good reliability, demonstrating low measurement error and a high ability to detect change in physical status over time.

The QuickScreen © assessment has been trialled in several clinical settings with general practitioners, practice nurses and physiotherapists, where it was found to be quick and easy to administer, taking an average of 10 minutes to complete. The clinicians reported that the assessment provided useful information about risk factors and guided the implementation of intervention strategies. The QuickScreen © consists of the following measures: previous falls, medication usage, vision, peripheral sensation, lower limb strength, balance and co-ordination and requires the use of minimal equipment. This makes it a portable, easy to use assessment which has a low cost yet high accuracy in determining who is at risk of falling and which particular factors contribute to that risk.

The assessment also allows the user to calculate the combined risk increase that the identified risk factors present for future falls. The inclusion of this scoring system in the QuickScreen © allows for the identification of people who are at a high risk of falling, in addition to its ability to determine which specific factors contribute to that risk. This information can then be used to determine which intervention strategies are likely to be most beneficial in reducing the risk of future falls.

Reference: Tiedemann A. The development of a validated falls risk assessment for use in clinical practice [PhD Thesis]. Sydney (NSW): University of New South Wales; 2006

FAQs for QuickScreen©

1. What is the difference between QuickScreen© and FallScreen
Answer: both are multifactorial falls risk assessment tools, which are designed to identify people at risk of falls, to identify which specific risk factors are placing the person at risk and to guide interventions for the prevention of future falls. The differences lie in a) the time taken to administer the assessments- Fallscreen takes 15-20mins, QuickScreen© takes 5-10 minutes, b) the need for specialized testing equipment- Fallscreen requires the use of several pieces of specialized equipment which is less portable than the QuickScreen©, which requires minimal equipment and fits into a small satchel, c) the interpretation of test results- Fallscreen requires the use of computer software to interpret the assessment results, QuickScreen© involves a simple scoring procedure which does not require computer processing, d) quantitative versus qualitative scoring- Fallscreen has a quantitative scoring method, allowing for the change in individual test scores to be compared over time, QuickScreen© uses a pass/fail tick box method of scoring, making it less accurate for comparison over time, e) cost- Fallscreen is a more comprehensive assessment with specialized equipment and costs $4,000(excl. GST) for the short version and $8000(excl GST) for the long version, QuickScreen© costs $300.00 (excl. GST). Delivery cost upon request.

2. What is the most appropriate way to use the visual acuity chart?
Answer: the protective sheet should be moved when doing the vision test. Tilt the chart to remove glare or change the light source.

3. Can the visual acuity chart be used with NESB (Non English speaking Background) clients?
Answer: the vision chart has not been used with NESB clients and is not validated with them. There are vision charts available for NESB clients which test the patients ability to identify the orientation of a shape (we have one here with E’s) but they have not been validated for predicting falls as yet.

4. Most of my clients are failing the peripheral sensation test, what is the problem?
Answer: users need to consider whether they are applying the monofilament correctly. It must bend and be applied for approx one second to the lateral malleolus.

5. If someone has 2 or more risk factors in the same area, do they count as 1 or 2 risks in the risk calculation?
Answer: each risk factor counts separately for the risk score calculation even if they are from the same risk area- this is because they have all been shown to be predictors of risk independently.

6. Can I buy additional equipment once I have purchased a compete QuickScreen© kit?
Answer: the components of the kit are available for purchase once a complete kit has been bought. The visual acuity chart and the touch rod (aesthesiometer) can be purchased for $75 each, plus postage. The stopwatch, foot placement squares and 3m string, all in a storage case can be purchased for $20 plus postage.

7. Do I need to use the square template when carrying out the near tandem stand test?
Answer: yes, the template ensures correct positioning of the feet for the test and should be used.

8. Does the patient need to remove socks/ stockings for the touch sensation test?
Answer: Yes, the touch sensation test must be conducted on bare skin.

If you have any further questions regarding QuickScreen please contact the Falls and Balance team at fallscreen@neura.edu.au. To order a kit please use the order form at the top of this page.

See what’s going on at NeuRA


Ten siblings. One third live (or have passed away) with dementia.

The scourge of dementia runs deep in Lorna Clement's family. Of the eleven children her dear parents raised, four live (or have passed away) with complications of the disease. Her mother also died of Alzheimer's disease, bringing the family total to five. This is the mystery of dementia - One family, with two very different ageing outcomes. You will have read that lifestyle is an important factor in reducing the risk of dementia. We also know diet is a key factor, and an aspect that Dr Ruth Peter's is exploring at NeuRA. Along with leading teams delivering high profile evidence synthesis work in the area of dementia risk reduction, Dr Peters has a particular interest in hypertension (that is, high blood pressure) and in the treatment of hypertension in older adults. “We have known for a while that treating high blood pressure reduces the risk of cardiovascular disease and stroke, but it is becoming clearer that controlling blood pressure may also help to reduce the risk of cognitive decline and dementia. Now we need to know what the best blood pressure is to protect brain health.” You are invited to read more about Lorna's story and Dr Peter's work, by clicking 'Read the full story' below. Please support dementia research at NeuRA Will you consider a gift today to help Dr Peter's unlock the secrets of healthy ageing and reduce the risk of dementia? Research into ageing and dementia at NeuRA will arm doctors and other medical professionals with the tools they need to help prevent dementia in our communities. Thank you for your support.